Kurt Kroenke, M.D., authored an editorial in JAMA Network Open highlighting new research on the PHQ-3, a shortened version of the widely used PHQ-9 depression screening tool. Dr. Kroenke noted the study’s strengths, including its large and diverse sample, while emphasizing the need for future research in clinical settings.
-
Research
- Experts
In The News
View AllAP News features LOINC
LOINC, developed and maintained by the Regenstrief Institute, was featured by AP...
Influence
View AllPrimary Care and Survival: Implications for Research and Policy
Published in the Journal of General Internal Medicine. Here is a link...
- About
Regenstrief is dedicated to pioneering transformative solutions for a healthier world.
- The Latest
- Collaboration
Generating Evidence Across the Full Arc of Disease
Regenstrief Institute x Merck The Question Clinical trials establish whether...
Evaluating AI-Enabled Trial Screening in Real-World Oncology Workflows
Regenstrief, Triomics and Indiana University Health, supported by an independent...
- Experts



